Ann Belmans
Appearances
- DateMay 18, 2024Our previous pilot study showed that treatment with the histamine 1 receptor antagonist ebastine improved symptoms in patients with irritable bowel syndrome (IBS)…
Presenter
Speakers
Amsterdam UMC, University of Amsterdam
